UnitedHealth Group (NYSE:UNH) Now Covered by Evercore ISI

Equities researchers at Evercore ISI started coverage on shares of UnitedHealth Group (NYSE:UNH) in a research note issued to investors on Tuesday, TipRanks reports. The brokerage set a “buy” rating and a $285.00 price target on the healthcare conglomerate’s stock. Evercore ISI’s price target suggests a potential upside of 1.60% from the stock’s current price.

UNH has been the subject of a number of other reports. UBS Group upped their price objective on UnitedHealth Group from $257.00 to $279.00 and gave the stock a “neutral” rating in a report on Wednesday, December 4th. Deutsche Bank initiated coverage on UnitedHealth Group in a research note on Thursday, September 12th. They issued a “hold” rating and a $263.00 target price for the company. Piper Jaffray Companies boosted their target price on UnitedHealth Group from $312.00 to $325.00 and gave the company an “overweight” rating in a research note on Wednesday, December 4th. ValuEngine raised UnitedHealth Group from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Barclays boosted their target price on UnitedHealth Group from $260.00 to $305.00 and gave the company an “overweight” rating in a research note on Monday, December 2nd. Five analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $299.48.

UNH opened at $280.50 on Tuesday. The stock has a 50-day moving average price of $265.65 and a 200-day moving average price of $246.96. UnitedHealth Group has a 12-month low of $208.07 and a 12-month high of $283.04. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $265.41 billion, a P/E ratio of 21.78, a PEG ratio of 1.48 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The firm had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. During the same period in the prior year, the business earned $3.41 EPS. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group will post 14.99 EPS for the current year.

In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, Director Richard T. Burke sold 25,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of $236.56, for a total value of $5,914,000.00. Following the transaction, the director now directly owns 163,331 shares of the company’s stock, valued at approximately $38,637,581.36. The disclosure for this sale can be found here. In the last three months, insiders sold 38,577 shares of company stock valued at $9,398,080. 0.82% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Berkeley Capital Partners LLC raised its position in UnitedHealth Group by 7.4% during the 2nd quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock valued at $542,000 after purchasing an additional 153 shares during the last quarter. Granite Investment Partners LLC raised its position in UnitedHealth Group by 1.8% during the 2nd quarter. Granite Investment Partners LLC now owns 67,540 shares of the healthcare conglomerate’s stock valued at $16,480,000 after purchasing an additional 1,193 shares during the last quarter. Everence Capital Management Inc. raised its position in UnitedHealth Group by 5.1% during the 2nd quarter. Everence Capital Management Inc. now owns 18,890 shares of the healthcare conglomerate’s stock valued at $4,609,000 after purchasing an additional 910 shares during the last quarter. Seeyond raised its position in UnitedHealth Group by 3.8% during the 2nd quarter. Seeyond now owns 10,299 shares of the healthcare conglomerate’s stock valued at $2,513,000 after purchasing an additional 373 shares during the last quarter. Finally, Bronfman E.L. Rothschild L.P. raised its position in UnitedHealth Group by 12.3% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 18,658 shares of the healthcare conglomerate’s stock valued at $4,553,000 after purchasing an additional 2,038 shares during the last quarter. 85.48% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Is it better to buy a fund with a higher or lower NAV?

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.